Mahfouz, R. Z., Jankowska, A., Ebrahem, Q., Gu, X., Visconte, V., Tabarroki, A., . . . Saunthararajah, Y. (2013). Increased CDA expression/activity in males contributes to decreased cytidine analogue half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.
Chicago Stili AlıntıMahfouz, Reda Z., et al. Increased CDA Expression/activity in Males Contributes to Decreased Cytidine Analogue Half-life and Likely Contributes to Worse Outcomes With 5-azacytidine or Decitabine Therapy. 2013.
MLA AlıntıMahfouz, Reda Z., et al. Increased CDA Expression/activity in Males Contributes to Decreased Cytidine Analogue Half-life and Likely Contributes to Worse Outcomes With 5-azacytidine or Decitabine Therapy. 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..